Loading company…
Xyall develops automated tissue dissection systems for molecular diagnostic laboratories.
Xyall combines robotics and digital pathology in its Tissector systems and annotation software. Its products serve laboratories with different throughput needs. Founded in 2018, the company is based in Eindhoven, Netherlands. It raised EUR 7.6 million in venture funding led by Capricorn Partners in February 2026.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in